305 related articles for article (PubMed ID: 11325859)
1. Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas.
Ding H; Roncari L; Shannon P; Wu X; Lau N; Karaskova J; Gutmann DH; Squire JA; Nagy A; Guha A
Cancer Res; 2001 May; 61(9):3826-36. PubMed ID: 11325859
[TBL] [Abstract][Full Text] [Related]
2. Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model.
Ding H; Shannon P; Lau N; Wu X; Roncari L; Baldwin RL; Takebayashi H; Nagy A; Gutmann DH; Guha A
Cancer Res; 2003 Mar; 63(5):1106-13. PubMed ID: 12615729
[TBL] [Abstract][Full Text] [Related]
3. Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice.
Weissenberger J; Steinbach JP; Malin G; Spada S; Rülicke T; Aguzzi A
Oncogene; 1997 May; 14(17):2005-13. PubMed ID: 9160879
[TBL] [Abstract][Full Text] [Related]
4. Increased neurofibromatosis 1 gene expression in astrocytic tumors: positive regulation by p21-ras.
Gutmann DH; Giordano MJ; Mahadeo DK; Lau N; Silbergeld D; Guha A
Oncogene; 1996 May; 12(10):2121-7. PubMed ID: 8668337
[TBL] [Abstract][Full Text] [Related]
5. Pathological and molecular progression of astrocytomas in a GFAP:12 V-Ha-Ras mouse astrocytoma model.
Shannon P; Sabha N; Lau N; Kamnasaran D; Gutmann DH; Guha A
Am J Pathol; 2005 Sep; 167(3):859-67. PubMed ID: 16127163
[TBL] [Abstract][Full Text] [Related]
6. Transformation of astrocytes in transgenic mice expressing SV40 T antigen under the transcriptional control of the glial fibrillary acidic protein promoter.
Danks RA; Orian JM; Gonzales MF; Tan SS; Alexander B; Mikoshiba K; Kaye AH
Cancer Res; 1995 Oct; 55(19):4302-10. PubMed ID: 7671240
[TBL] [Abstract][Full Text] [Related]
7. Astrocyte-specific expression of CDK4 is not sufficient for tumor formation, but cooperates with p53 heterozygosity to provide a growth advantage for astrocytes in vivo.
Huang ZY; Baldwin RL; Hedrick NM; Gutmann DH
Oncogene; 2002 Feb; 21(9):1325-34. PubMed ID: 11857076
[TBL] [Abstract][Full Text] [Related]
8. Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma.
Sonoda Y; Ozawa T; Hirose Y; Aldape KD; McMahon M; Berger MS; Pieper RO
Cancer Res; 2001 Jul; 61(13):4956-60. PubMed ID: 11431323
[TBL] [Abstract][Full Text] [Related]
9. Mice with GFAP-targeted loss of neurofibromin demonstrate increased axonal MET expression with aging.
Su W; Xing R; Guha A; Gutmann DH; Sherman LS
Glia; 2007 May; 55(7):723-33. PubMed ID: 17348023
[TBL] [Abstract][Full Text] [Related]
10. Expression of oligodendrocytic mRNAs in glial tumors: changes associated with tumor grade and extent of neoplastic infiltration.
Landry CF; Verity MA; Cherman L; Kashima T; Black K; Yates A; Campagnoni AT
Cancer Res; 1997 Sep; 57(18):4098-104. PubMed ID: 9307299
[TBL] [Abstract][Full Text] [Related]
11. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
[TBL] [Abstract][Full Text] [Related]
12. Astrocyte heterogeneity revealed by expression of a GFAP-LacZ transgene.
Lee Y; Su M; Messing A; Brenner M
Glia; 2006 May; 53(7):677-87. PubMed ID: 16482522
[TBL] [Abstract][Full Text] [Related]
13. Murine model of Alexander disease: analysis of GFAP aggregate formation and its pathological significance.
Tanaka KF; Takebayashi H; Yamazaki Y; Ono K; Naruse M; Iwasato T; Itohara S; Kato H; Ikenaka K
Glia; 2007 Apr; 55(6):617-31. PubMed ID: 17299771
[TBL] [Abstract][Full Text] [Related]
14. Astrocytes give rise to oligodendrogliomas and astrocytomas after gene transfer of polyoma virus middle T antigen in vivo.
Holland EC; Li Y; Celestino J; Dai C; Schaefer L; Sawaya RA; Fuller GN
Am J Pathol; 2000 Sep; 157(3):1031-7. PubMed ID: 10980141
[TBL] [Abstract][Full Text] [Related]
15. Loss of GFAP expression in high-grade astrocytomas does not contribute to tumor development or progression.
Wilhelmsson U; Eliasson C; Bjerkvig R; Pekny M
Oncogene; 2003 May; 22(22):3407-11. PubMed ID: 12776191
[TBL] [Abstract][Full Text] [Related]
16. Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomas.
Jacob K; Quang-Khuong DA; Jones DT; Witt H; Lambert S; Albrecht S; Witt O; Vezina C; Shirinian M; Faury D; Garami M; Hauser P; Klekner A; Bognar L; Farmer JP; Montes JL; Atkinson J; Hawkins C; Korshunov A; Collins VP; Pfister SM; Tabori U; Jabado N
Clin Cancer Res; 2011 Jul; 17(14):4650-60. PubMed ID: 21610151
[TBL] [Abstract][Full Text] [Related]
17. Astrocyte-specific overexpression of insulin-like growth factor-I promotes brain overgrowth and glial fibrillary acidic protein expression.
Ye P; Popken GJ; Kemper A; McCarthy K; Popko B; D'Ercole AJ
J Neurosci Res; 2004 Nov; 78(4):472-84. PubMed ID: 15468174
[TBL] [Abstract][Full Text] [Related]
18. GFAP promoter driven transgenic expression of PDGFB in the mouse brain leads to glioblastoma in a Trp53 null background.
Hede SM; Hansson I; Afink GB; Eriksson A; Nazarenko I; Andrae J; Genove G; Westermark B; Nistér M
Glia; 2009 Aug; 57(11):1143-53. PubMed ID: 19115382
[TBL] [Abstract][Full Text] [Related]
19. Characterization and transformation potential of "Synthetic" astrocytes differentiated from murine embryonic stem cells.
Kamnasaran D; Hawkins C; Guha A
Glia; 2008 Mar; 56(4):457-70. PubMed ID: 18205175
[TBL] [Abstract][Full Text] [Related]
20. Ras p21 expression in brain tumors: elevated expression in malignant astrocytomas and glioblastomas multiforme.
Arvanitis D; Malliri A; Antoniou D; Linardopoulos S; Field JK; Spandidos DA
In Vivo; 1991; 5(4):317-21. PubMed ID: 1667267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
